JPMorgan Chase & Co. Sells 163,708 Shares of ARK Genomic Revolution ETF (BATS:ARKG)
JPMorgan Chase & Co. decreased its position in shares of ARK Genomic Revolution ETF (BATS:ARKG – Free Report) by 5.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,791,571 shares of the company’s stock after selling 163,708 shares during the quarter. JPMorgan Chase […]
JPMorgan Chase & Co. decreased its position in shares of ARK Genomic Revolution ETF (BATS:ARKG – Free Report) by 5.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,791,571 shares of the company’s stock after selling 163,708 shares during the quarter. JPMorgan Chase […]
